High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV.
Hiroaki SasakiNobuyuki MiyataYukihiro YoshimuraNatsuo TachikawaPublished in: Infection (2022)
supports the clinical benefit of therapeutic and prophylactic use of REGN-COV from the serological point of view.